This mechanism can be universal for majority of interactions of LDLR family receptors with their ligands, in particular, those involved in pathogenesis of hemostasis, type 2 diabetes, obesity, Parkinson's disease, and Alzheimer's disease, while its understanding can facilitate development of medical treatments for those. This evidence concerns the gene LDLR and obesity due to melanocortin 4 receptor deficiency.